You searched for: amyloidose (Danska - Engelska)

amyloidose
amyloidosis

para-amyloidose
para-amyloidosis

conjunctival amyloidose
amyloidosis of the conjunctiva

gottron's amyloidose
gottron amyloidosis

meget sjældne: amyloidose
very rare: amyloidosis

patienter tidligere behandlet for al-amyloidose
patients with previously treated light-chain (al) amyloidosis

· hvis du er blevet diagnosticeret med lidelsen amyloidose.
· if you have been diagnosed in the past with a condition called amyloidosis.

patienter med tidligere behandlet let-kæde al-amyloidose
patients with previously treated light-chain (al) amyloidosis

anafylaktisk shock, amyloidose, immunkompleksmedieret (type iii-) overfølsomhedsreaktion
anaphylactic shock, amyloidosis, type iii immune complex mediated reaction

som et peptid, kan enfuvirtid forårsage kutan amyloidose på injektionsstedet.
as a peptide, enfuvirtide can cause cutaneous amyloidosis at the injection site.

patienter med kardiel amyloidose eller plasmacelleleukæmi blev udelukket fra dette studie.
patients with cardiac amyloidosis or plasma cell leukemia were excluded from this study.

anafylaktisk shock, amyloidose, immunkompleks-medieret (type iii) overfølsomhedsreaktion
anaphylactic shock, amyloidosis, type iii immune complex mediated reaction

virkningen af bortezomibs proteasomhæmning ved sygdomme forbundet med proteinakkumulation, f. eks. amyloidose, kendes ikke.
the impact of proteasome inhibition by bortezomib on disorders associated with protein accumulation such as amyloidosis is unknown.

amyloidose virkningen af bortezomibs proteasomhæmning ved sygdomme forbundet med proteinakkumulation, f. eks. amyloidose, kendes ikke.
amyloidosis the impact of proteasome inhibition by bortezomib on disorders associated with protein accumulation such as amyloidosis is unknown.

under rutinemæssig signal gennemgang, blev en gennemgang af fem sagsrapporter om amyloidose tilfælde relateret til enfuvirtid, udtaget fra eudravigilance.
during routine signal detection activities, a review of five case reports of high level term amyloidosis cases related to enfuvirtide was extracted from eudravigilance.

52 • problemer med hjertet eller blodtrykket. • en sygdom som kaldes amyloidose. • stakåndethed eller hoste
• heart or blood pressure problems.

chmp bemærkede, at vyndaqel var mere effektivt end placebo til at udskyde nervebeskadigelse hos patienter med transthyretin amyloidose, bortset fra hos de patienter, som forlod undersøgelsen, fordi de havde behov for en levertransplantation.
the chmp noted that, apart from in patients who left the study because they needed a liver transplant, vyndaqel was more effective than placebo in delaying nerve damage in patients with transthyretin amyloidosis.

det firma, der fremstiller velcade, skal gennemføre yderligere undersøgelser, som især fokuserer på fordelingen af velcade i kroppen (især efter gentagne doser) og risikoen for, at patienterne udvikler amyloidose (en ophobning af amyloid, en type protein, i kroppen) , eller at amyloidosen forværres.
the company that makes velcade will carry out further studies looking in particular at the distribution of velcade in the body (especially after repeated doses) , and at the risk of patients developing amyloidosis (a build-up of amyloid, a type of protein, in the body) or of amyloidosis getting worse.